Cargando…
Experimental Limitations Using Reprogrammed Cells for Hematopoietic Differentiation
We review here our experiences with the in vitro reprogramming of somatic cells to induced pluripotent stem cells (iPSC) and subsequent in vitro development of hematopoietic cells from these iPSC and from embryonic stem cells (ESC). While, in principle, the in vitro reprogramming and subsequent diff...
Autores principales: | Seiler, Katharina, Tsuneto, Motokazu, Melchers, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237023/ https://www.ncbi.nlm.nih.gov/pubmed/22187531 http://dx.doi.org/10.1155/2011/895086 |
Ejemplares similares
-
Chemokine polyreactivity of IL7Rα(+)CSF-1R(+) lympho-myeloid progenitors in the developing fetal liver
por: Kajikhina, Katja, et al.
Publicado: (2015) -
Ectopic Runx1 Expression Rescues Tal-1-Deficiency in the Generation of Primitive and Definitive Hematopoiesis
por: Tornack, Julia, et al.
Publicado: (2013) -
M. tuberculosis Reprograms Hematopoietic Stem Cells to Limit Myelopoiesis and Impair Trained Immunity
por: Khan, Nargis, et al.
Publicado: (2020) -
Deep learning‐based identification of sinoatrial node‐like pacemaker cells from SHOX2/HCN4 double‐positive cells differentiated from human iPS cells
por: Wakimizu, Takayuki, et al.
Publicado: (2023) -
SHOX2 refines the identification of human sinoatrial nodal cell population in the in vitro cardiac differentiation
por: Wakimizu, Takayuki, et al.
Publicado: (2022)